0001415889-15-000169.txt : 20150116
0001415889-15-000169.hdr.sgml : 20150116
20150116175100
ACCESSION NUMBER: 0001415889-15-000169
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150114
FILED AS OF DATE: 20150116
DATE AS OF CHANGE: 20150116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001070494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 061376651
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11085 TORREYANA ROAD
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-558-2871
MAIL ADDRESS:
STREET 1: 11085 TORREYANA ROAD
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hacksell Uli
CENTRAL INDEX KEY: 0001291962
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50768
FILM NUMBER: 15533514
MAIL ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BOULEVARD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
form4-01162015_020151.xml
X0306
4
2015-01-14
0001070494
ACADIA PHARMACEUTICALS INC
ACAD
0001291962
Hacksell Uli
11085 TORREYANA ROAD #100
SAN DIEGO
CA
92121
true
true
false
false
CEO
Common Stock
2015-01-14
4
M
0
30000
2
A
30000
D
Common Stock
2015-01-14
5
G
0
30000
0
D
0
D
Common Stock
2015-01-14
5
G
0
30000
0
A
145549
I
By Family Trust
Common Stock
2015-01-14
4
S
0
30000
33.981
D
115549
I
By Family Trust
Stock Option (right to buy)
2
2015-01-14
4
M
0
30000
0
D
2018-10-19
Common Stock
30000
0
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in March 2014.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $33.68 to $34.33 per share, inclusive. The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range.
50% of the shares subject to the stock option vested and became exercisable on October 20, 2010. The remaining shares vested in equal monthly installments over the following 2 years.
/s/ Glenn F. Baity, Attorney-in-Fact
2015-01-16